A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes
Froukje Vanweert(Maastricht University), Esther Phielix(Maastricht University), Zoltàn Arany(Cardiovascular Institute Hospital), Megan C. Blair(University of Pennsylvania), Marc R. Bornstein(University of Pennsylvania), Joris Hoeks(Maastricht University Medical Centre), Tineke van de Weijer(Maastricht University Medical Centre), Vera B. Schrauwen‐Hinderling(Maastricht University Medical Centre), Patrick Schrauwen(Leiden University Medical Center), Edmundo Erazo Tapia(Maastricht University), Matthijs K. C. Hesselink(Maastricht University Medical Centre), Michael D. Neinast(Princeton University)
Cited by 82
Related Papers
Branched Chain Amino Acids
|Annual Review of Physiology|2018|686
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
|New England Journal of Medicine|2016|597
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
|Circulation|2019|346